Pharmaceutical Biotechnology - Faculty for Chemistry and Pharmacy

Publications Dr. Andreas Roidl





  • miR-200c regulates cell cycle, proliferation and migration in cancer cells by targeting the proto-oncogene KRAS, Florian Koop, Ernst Wagner and Andreas Roidl, Keystone Symposia “Noncoding RNAs in Development and Cancer” Vancouver, BC, Canada (January 2013)
  • miR-143 dependent transgene expression for cancer gene therapy, Florian Kopp, Maria Schnödt, Rudolf Haase, Ernst Wagner, Manfred Ogris and Andreas Roidl, Deutsche Gesellschaft für Gentherapie; Jahrestagung 2012 Frankfurt, Germany (March 2012)
  • Salinomycin as an effective drug in combinatorial treatment of breast carcinoma, Prajakta Oak, Florian Kopp, Joachim Ellwart, Axel Ullrich, Ernst Wagner, Pjotr Knyazev and Andreas Roidl, AACR Special Conference Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications San Francisco, CA, USA (October 2011)

* Correspondence author